Director/PDMR Shareholding
Updated : 15:17
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Ms E Walmsley | ||||||
b) | Position/status | Chief Executive Officer | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr R G Connor | ||||||
b) | Position/status | President, Global Manufacturing & Supply | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr S Dingemans | ||||||
b) | Position/status | Chief Financial Officer | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr N Hirons | ||||||
b) | Position/status | SVP, Global Ethics & Compliance | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr L Miels | ||||||
b) | Position/status | President, Global Pharmaceuticals | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr D S Redfern | ||||||
b) | Position/status | Chief Strategy Officer | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Ms C Thomas | ||||||
b) | Position/status | SVP, Human Resources | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mr P C Thomson | ||||||
b) | Position/status | President, Global Affairs | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
16 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Mrs V A Whyte | ||||||
b) | Position/status | Company Secretary | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information Aggregated volume Price |
18 Ordinary Shares £14.6664
| ||||||
e) | Date of the transaction | 2018-05-10 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
This information is provided by RNS